Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Schedule of Antidilutive Securities

The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:

	Three and Nine Months Ended September 30,
	2024	2023
Public warrants	500,000	500,000
Private warrants	13,300	13,300
Stock options	290,858	336,345
Unvested restricted stock units	285,747	296,195
Warrants issued in connection with 15th amendment to Credit Agreement	—	80,000
Total common stock equivalents	1,089,905	1,225,840